Journal Title：Current Pharmaceutical Biotechnology

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

DNA/protein engineering and processing

Synthetic biotechnology

Omics (genomics, proteomics, metabolomics and systems biology)

Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)

Drug delivery and targeting

Nanobiotechnology

Molecular pharmaceutics and molecular pharmacology

Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)

Pharmacokinetics and pharmacodynamics

Applied Microbiology

Bioinformatics (computational biopharmaceutics and modeling)

Environmental biotechnology

Regenerative medicine (stem cells, tissue engineering and biomaterials)

Translational immunology (cell therapies, antibody engineering, xenotransplantation)

Industrial bioprocesses for drug production and development

Biosafety

Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

《當代制藥生物技術》旨在涵蓋制藥生物技術領域所有最新和杰出的發(fā)展。該期刊的每一期都包括及時深入的評論、原創(chuàng)研究文章和該領域領導者撰寫的信函，涵蓋制藥生物技術科學領域的一系列當前主題。歡迎邀請和主動撰寫評論文章。該期刊鼓勵投稿描述藥物發(fā)現和藥理應用界面的研究，涉及體外調查和臨床前或臨床研究。該期刊范圍內的科學領域包括與制藥科學和生物技術相關的藥物化學、生物化學和遺傳學、分子和細胞生物學以及聚合物和材料科學。此外，該期刊還考慮與制藥相關的食品化學的綜合研究和研究進展。感興趣的領域包括：

DNA/蛋白質工程和加工

合成生物技術

組學（基因組學、蛋白質組學、代謝組學和系統生物學）

治療生物技術（基因治療、肽抑制劑、酶）

藥物輸送和靶向

納米生物技術

分子藥劑學和分子藥理學

分析生物技術（生物傳感、檢測生物分析物的先進技術）

藥代動力學和藥效學

應用微生物學

生物信息學（計算生物藥劑學和建模）

環(huán)境生物技術

再生醫(yī)學（干細胞、組織工程和

生物材料

轉化免疫學（細胞療法、抗體工程、異種移植）

藥物生產和開發(fā)的工業(yè)生物過程

生物安全

生物技術倫理

歡迎刊登關于關鍵主題的特刊，提供有關前沿研究領域和技術進步的最新綜合信息。

《當代制藥生物技術》是一本重要的期刊，適合希望隨時了解最新和最重要發(fā)展的學術、臨床、政府和制藥科學家。

Current Pharmaceutical Biotechnology創(chuàng)刊于2000年，由Bentham Science Publishers B.V.出版商出版，收稿方向涵蓋醫(yī)學 - 生化與分子生物學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 一般,3-6周 ，影響因子指數2.2，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。